Similar articles

• The dilemma of vasopressors and vasodilators in the therapy of shock.

  Shoemaker WC, Brown RS. Shoemaker WC, et al. Surg Gynecol Obstet. 1971 Jan;132(1):51-7. Surg Gynecol Obstet. 1971. PMID: 5538813 No abstract available.
• Oxygen utilization in experimental shock: survey of some recent studies.

  Anas P, Neely WA, Hardy JD. Anas P, et al. Am Surg. 1968 Oct;34(10):706-10. Am Surg. 1968. PMID: 5680927 No abstract available.
• Pressor agents in cardiogenic shock.

  Corday E, Lillehei RC. Corday E, et al. Am J Cardiol. 1969 Jun;23(6):900-10. doi: 10.1016/0002-9149(69)90389-0. Am J Cardiol. 1969. PMID: 5785170 No abstract available.
• The role of vasoactive agents in shock therapy.

  Ogburn P. Ogburn P. Vet Clin North Am. 1976 May;6(2):287-95. doi: 10.1016/s0091-0279(76)50036-0. Vet Clin North Am. 1976. PMID: 775751 Review.
• Shock in myocardial infarction--medical treatment.

  Kuhn LA. Kuhn LA. Am J Cardiol. 1970 Dec;26(6):578-87. doi: 10.1016/0002-9149(70)90410-8. Am J Cardiol. 1970. PMID: 4938984 Review. No abstract available.